Breakthrough zygomycoses in patients receiving antifungal therapy with voriconazole.

被引：0
|
作者：
Balasubramanian, L [1 ]
Trifilio, SM [1 ]
Tallman, M [1 ]
Mehta, J [1 ]
Bennett, C [1 ]
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：601S / 601S
页数：1
相关论文
共 50 条
  • [1] A multi-institution retrospective case report analysis of emergence of breakthrough zygomycoses in patients on prior voriconazole therapy.
    Trifilio, SM
    Balasubramanian, L
    Mehta, J
    Tallman, MS
    Kennedy, L
    Bennett, CL
    Kontoyiannis, DP
    BLOOD, 2005, 106 (11) : 902A - 902A
  • [2] Breakthrough Candida infections in patients receiving voriconazole
    Gerzenshtein, L
    Patel, SM
    Scarsi, KK
    Postelnick, MJ
    Flaherty, JP
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (7-8) : 1342 - 1345
  • [3] Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole.
    Trifilio, Steve
    Singhal, Seema
    Williams, Stephanie
    Winter, Jane
    Tallman, Martin
    Gordon, Leo
    Frankfurt, Olga
    Evens, Andrew
    Mehta, Jayesh
    BLOOD, 2006, 108 (11) : 806A - 807A
  • [4] Tacrolimus Continuous Infusion in Lung Transplantation - A Comparison of Pharmacokinetics in Patients Receiving Itraconazole Versus Voriconazole.
    Feist, Ashley A.
    Derry, Katrina L.
    Lane, James R.
    Box, Kevin
    Connor, James
    Tran, Anhtuan
    Yung, Gordon
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 461 - 461
  • [5] RISK FACTORS ASSOCIATED WITH BREAKTHROUGH CANDIDEMIA IN PATIENTS RECEIVING PROPHYLACTIC EMPIRIC ANTIFUNGAL THERAPY
    Lam, Simon W.
    Kludze-Forson, Maabo
    Eschenauer, Gregory A.
    CRITICAL CARE MEDICINE, 2008, 36 (12) : A113 - A113
  • [6] Zygomycosis in allogeneic hematopoietic stem cell transplant recipients receiving prophylactic voriconazole.
    De Magalhaes-Silverman, M
    Carter, T
    Gingrich, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 593S - 593S
  • [7] Serum voriconazole level variability in patients with hematological malignancies receiving voriconazole therapy
    Saini, Lalit
    Seki, Jack T.
    Kumar, Deepali
    Atenafu, Eshetu G.
    Cole, David E. C.
    Wong, Betty Y. L.
    Bozovic, Andrea
    Brandwein, Joseph M.
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2014, 25 (05): : 271 - 276
  • [8] Complete heart block in a patient receiving combination antifungal therapy with voriconazole and caspofungin: Is there a link?
    Djurkovic, S
    Voigt, L
    McAleer, E
    Ross-Douglas, B
    Pastores, SM
    Halpern, NA
    CHEST, 2005, 128 (04) : 417S - 418S
  • [9] Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia
    Oren, H
    CLINICAL INFECTIOUS DISEASES, 2005, 40 (05) : 770 - 771
  • [10] Tacrolimus dosing in allogeneic hematopoietic stem cell transplant (HSCT) recipients receiving concomitant voriconazole.
    Trifilio, Steven
    Pi, Judy
    Singhal, Seema
    Frankfurt, Olga
    Evens, Andrew
    Gordon, Leo
    Tallman, Martin
    Winter, Jane
    Williams, Stephanie
    Mehta, Jayesh
    BLOOD, 2007, 110 (11) : 315B - 315B
12345